Cannabis Clinical Trials

Visit the Harvest One Cannabis Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors. Harvest One Cannabis Inc. – Favourable Results from Phase 2 Clinical Trials using Satipharm Capsules VANCOUVER, Feb. 1, 2018 /CNW/ – Harvest One Cannabis Inc. (TSXV: HVT) (“Harvest One” or the “Company”) through its […]

by

Ready for trials: Researchers exploring the benefits of medicinal cannabis include (from left) Matthew Spitzer, Associate Professor Phillip Good, Professor Janet Hardy and Georgie Cupples at Mater Research. QUEENSLAND researchers will soon start a major clinical trial to find out the benefits of medicinal cannabis for cancer patients receiving palliative care. “We are delighted to […]

by

An Australian GP has criticised access to medicinal cannabis in Australia as “unworkable”. Caroline*, a doctor from Adelaide, said the oppressive bureaucracy surrounding medicinal cannabis sits in contrast to the way pharmaceutical opioids are dispensed to patients. Medicinal cannabis was legalised in November 2016, but nine.com.au has been contacted by a number of people who claim […]

by

Experts on both sides of the medicinal cannabis debate are arguing over an editorial published in the Medical Journal of Australia (MJA) that has been labeled “scaremongering” and “patronising”. The niche corner of social media devoted to medicinal cannabis was ablaze on Monday after the MJA publishing a story from the Royal Australasian College of […]

by

Medical cannabis was found to safely and significantly reduce chronic pain in older patients with multiple sclerosis (MS) and a wide range of other conditions, researchers in Israel report. Led by scientists at Ben-Gurion University of the Negev (BGU) and the Cannabis Clinical Research Institute at Soroka University Medical Center, the study was published in the European […]

by

RAMAT GAN, Israel, Feb. 20, 2018 /PRNewswire/ – OWC Pharmaceutical Research Corp. (OTCQB: OWCP), (“OWC” or the “Company”), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced the appointment of Dr. Oron Yacoby Zeevias its Chief Scientific Officer (CSO). Dr. Yacoby Zeevi has more than 20 years of extensive scientific […]

by

Clinicians say they are cautious as demand for prescription cannabinoids outruns research on safety profile and effectiveness Doctors have written to the Medical Journal of Australia (MJA) on behalf of the Royal Australasian College of Physicians (RACP), sharing their concerns that the introduction of medicinal cannabis has not followed the usual research-based safety and effectiveness […]

by

Start-up Greenlight has attracted government funds to study cannabis oil, writes Trish Dromey James Linden, CEO and founder, Greenlight Medicines. Picture: Peter Houlihan/ Fennell WITH plans to establish itself as the global leader in the production of prescription medicines using cannabis, Irish start-up Greenlight Medicines is aiming high. In September, the company, which is the […]

by

Whilst in the Netherlands Alfie was prescribed the drugs Bedica and Bendrolite, which contain small amounts of THC. Describing the effect the cannabis treatment had on Alfie, his grandmother, Maggie Deacon, said: “Alfie has gone from a death sentence to the prospect of a more normal life with school, friends and fun, in his own familiar […]

by